4KGC | Nucleosome Core Particle Containing (ETA6-P-CYMENE)-(1, 2-ETHYLENEDIAMINE)-RUTHENIUM | date | |
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Adhireksan, Z., Davey, C.A. | ||||||||||||||||||||||
compound | source | ||||||||||||||||||||||
symmetry |
| ||||||||||||||||||||||
crystal cell |
| ||||||||||||||||||||||
method | X-Ray Diffraction | resolution | 2.69 | ||||||||||||||||||||
ligand | HRU, MG, SO4 | enzyme |
| ||||||||||||||||||||
Gene Ontology |
| ||||||||||||||||||||||
Primary reference | Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity., Adhireksan Z, Davey GE, Campomanes P, Groessl M, Clavel CM, Yu H, Nazarov AA, Yeo CH, Ang WH, Droge P, Rothlisberger U, Dyson PJ, Davey CA, Nat Commun. 2014 Mar 18;5:3462. doi: 10.1038/ncomms4462. PMID:24637564 |
Data retrieval |
View 4KGC in 3D |
Visual 3D analysis of 4KGC |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4KGC |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |